Peter Edward Lobie

17PUBLICATIONS
75CO-AUTHORS
Predictive and prognostic markersMolecular targetsNeural engineeringMedical infection agents (incl. prions)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 19, 2026
PAX9 activates autophagy through a transcription-dependent mechanism, promoting EGFR degradation to restrict cell survival in oral cancer.

|Jun 05, 2026
DP103 as a critical modulator of Wnt signaling and cancer stemness: implications for precision treatment in triple negative breast cancer.

|Mar 24, 2025
Astrocyte-secreted cues promote neural maturation and augment activity in human forebrain organoids.

Honghui Zheng, Yilin Feng, Jiyuan Tang

|Feb 21, 2025
TFF3 facilitates dormancy of anti-estrogen treated ER+ mammary carcinoma.

Shu Chen, Xi Zhang, Basappa Basappa

|Feb 07, 2025
Inhibition of TFF3 synergizes with c-MET inhibitors to decrease the CSC-like phenotype and metastatic burden in ER+HER2+ mammary carcinoma.

Chuyu He, Xuejuan Wang, Yi-Shiou Chiou

|Dec 10, 2024
TFF3 drives Hippo dependent EGFR-TKI resistance in lung adenocarcinoma.

Shuwei Zhang, Yan Qin Tan, Xi Zhang

Pageof 3

Frequent Collaborators

11 joint publications

Tao Zhu

9 joint publications

Vijay Pandey

8 joint publications

Basappa Basappa

3 joint publications

Gautam Sethi